Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.
You can purchase shares of Pyxis Oncology (NASDAQ:PYXS) through any online brokerage.
Other companies in Pyxis Oncology’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Atossa Therapeutics (NASDAQ:ATOS) and Sangamo Therapeutics (NASDAQ:SGMO).
Pyxis Oncology has a consensus price target of $12.40.
The stock price for Pyxis Oncology (NASDAQ: PYXS) is $3.52 last updated September 25, 2024 at 7:55 PM EDT.
There are no upcoming dividends for Pyxis Oncology.
Pyxis Oncology’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Pyxis Oncology.
Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.